Quarterly report · Q2
4539.TEDINET S100S7O5
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥298m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥167m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥10m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥58m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥752m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥27m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥31m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥339m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥31m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥50.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥48.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥50.7bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥592m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥916m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥351m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥394m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥148m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥8.72 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.31 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.07 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.43 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.51 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥546m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥544m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥5m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥355m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | −¥298m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥16m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥183m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥167m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 543
| Item | Context | Value | Unit |
|---|---|---|---|
| Raw materials and supplies | Prior1YearInstant | 3010000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 3422000000 | JPY |
| Income taxes receivable | Prior1YearInstant | 220000000 | JPY |
| Income taxes receivable | CurrentQuarterInstant | 8000000 | JPY |
| Other ca | Prior1YearInstant | 675000000 | JPY |
| Other ca | CurrentQuarterInstant | 625000000 | JPY |
| Current assets | Prior1YearInstant | 33436000000 | JPY |
| Current assets | CurrentQuarterInstant | 34677000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 4786000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 4709000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1636000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1476000000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 379000000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 383000000 | JPY |
| Land | Prior1YearInstant | 4344000000 | JPY |
| Land | CurrentQuarterInstant | 4344000000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 170000000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 159000000 | JPY |
| Construction in progress | Prior1YearInstant | 200000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 1361000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 11518000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 12435000000 | JPY |
| Patent right | Prior1YearInstant | 15000000 | JPY |
| Patent right | CurrentQuarterInstant | 13000000 | JPY |
| Right of trademark | Prior1YearInstant | 54000000 | JPY |
| Right of trademark | CurrentQuarterInstant | 50000000 | JPY |
| Sales rights ia | Prior1YearInstant | 383000000 | JPY |
| Sales rights ia | CurrentQuarterInstant | 241000000 | JPY |
| Lease assets ia | Prior1YearInstant | 47000000 | JPY |
| Lease assets ia | CurrentQuarterInstant | 50000000 | JPY |
| Software | Prior1YearInstant | 59000000 | JPY |
| Software | CurrentQuarterInstant | 48000000 | JPY |
| Telephone subscription right | Prior1YearInstant | 9000000 | JPY |
| Telephone subscription right | CurrentQuarterInstant | 9000000 | JPY |
| Intangible assets | Prior1YearInstant | 569000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 414000000 | JPY |
| Investment securities | Prior1YearInstant | 1385000000 | JPY |
| Investment securities | CurrentQuarterInstant | 1634000000 | JPY |
| Long term prepaid expenses | Prior1YearInstant | 496000000 | JPY |
| Long term prepaid expenses | CurrentQuarterInstant | 502000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 401000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 482000000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant | 57000000 | JPY |
| Lease and guarantee deposits | CurrentQuarterInstant | 54000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 353000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 315000000 | JPY |
| Other ioa | Prior1YearInstant | 414000000 | JPY |
| Other ioa | CurrentQuarterInstant | 414000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -61000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -61000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |